NIH R01 · 2025
Craving-based Digital Phenotyping During MOUD Treatment
Project Summary The current opioid crisis in the United States has staggering public health implications. Medications for opioid use disorder (MOUD) reduce morbidity and mortality in OUD, however rates of return to opioid use after treatment initiation are still high. Craving is a critical component of OUD, and the heterogeneity with which it occurs may provide insight into MOUD success. Non-invasive, wearable sensors have the potential to identify objective digital biomarkers that correlate with craving, which can further be leveraged to develop digital phenotypes of OUD using data from personal digital devices. However before this technology can realize its full potential, important…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.